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Abstract:  
Emergence of drug resistance is a major threat to public health. Many pathogens have developed resistance to most of the existing 
antibiotics, and multidrug-resistant and extensively drug resistant strains are extremely difficult to treat. This has resulted in an 
urgent need for novel drugs.  We describe a database called ‘Database of Drug Targets for Resistant Pathogens’ (DDTRP). The 
database contains information on drugs with reported resistance, their respective targets, metabolic pathways involving these 
targets, and a list of potential alternate targets for seven pathogens. The database can be accessed freely at 
http://bmi.icmr.org.in/DDTRP. 
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Background:  
Several pathogens have developed resistance against many of 
the currently available drugs and become a global health threat. 
Since infections caused by resistant pathogens are associated 
with higher morbidity and mortality than those caused by 
susceptible pathogens, increasing resistance is a major concern 
[1]. Also, while drug resistance is on the rise, discovery and 
development of newer drugs have been on the decline [2]. Thus, 
there is a pressing need for novel drugs to handle the problem 
of drug resistance. Genomic sequences of pathogens could 
serve as valuable tools in the search for newer drug targets. We 
employed an in silico approach to identify potential drug targets 
that could be exploited for drug discovery against some 
pathogens with reported drug resistance, viz. Mycobacterium 
tuberculosis,  Mycobacterium leprae, Plasmodium falciparum, P. 
vivax, Staphylococcus aureus, Sterptococcus pneumoniae and 
Nesseirria gonorrhea, and made the data available in the form of 
a database called DDTRP (Database of Drug Targets for 
Resistant Pathogens). The database can be accessed at 
http://bmi.icmr.org.in/DDTRP.  
   Figure 1: Flow of data in DDTRP 
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Methodology:  
From the list of currently available drugs for each of the 
selected pathogens, drugs reported to be associated with 
resistance due to mutation(s) in their respective target genes 
were selected and all enzymes involved in each of the targeted 
metabolic pathways were obtained from KEGG [3]. The protein 
sequences of these enzymes were compared with that of the 
human proteome using BLAST [4]. Proteins that had no 
orthologs in human at an e-value of 0.005 were identified as 
potential drug targets and made available in the DDTRP. Each 
target is cross-linked to other useful online resources. The 
database was built using XAMPP. The flowchart describing the 
development of the DDTRP is given in Figure 1.  
  
Results and Discussion:  
Eighty six potential targets were identified for M. tuberculosis, 
16 for M. leprae, 47 from Staphylococcus aureus, 43 for 
Streptococcus pneumoniae, 16 for Plasmodium falciparum, 11 for 
Plasmodium vivax and 46 for Neisseria gonorrhoeae.  Raman et al., 
(2008) [5] used the method of predicting potential drug targets 
in M. tuberculosis by comparing its whole genome with that of 
human proteome. Other investigators like Anishetty et al., 
(2007) [6] and Agüero et al., (2008) [7] have undertaken various 
efforts to identify and prioritize targets for tropical diseases 
including tuberculosis. Our strategy differs from that of others 
in that we have chosen as our initial dataset proteins from 
resistance associated metabolic pathways for the prediction of 
alternate drug targets. A total of 265 proteins were identified by 
us as potential drug targets for the seven pathogens. Since these 
targets are involved in metabolic pathways that are known to 
be critical for the growth or survival of the pathogen and their 
interruption could bring about a static or cidal effect on the 
pathogen, the shortlisted targets could be prioritized for further 
studies. The contents of the database have been summarized in 
Table 1 (see Supplementary material).  
 
Features of the database:  
The database has four browse options for each pathogen: i) 
currently available drugs with resistance, ii) targets of current 
drugs, iii) metabolic pathways involving each of the current 
targets, and iv) potential alternate drug targets. Details for each 
drug include a brief description of its composition and 
structure, mechanism of action, target protein, route of 
administration, dosage, absorption, adverse effects/toxicity and 
contra-indications. Links have also been provided to other 
online resources like DrugBank, PharmGKB, Medline Plus, 
DailyMed and RxList. Current and potential drug targets have 
been linked to GenBank, Swissprot (UniProt), KEGG, PDB, 
Pfam, InterPro, COG and other pathogen-specific databases 
wherever applicable. A provision has been made to browse the 
database via metabolic pathways. Figure 2 is a screen shot of 
the data provided for one of the potential targets in the 
database. 
 
 
Figure 2: Information page for a drug target of M. tuberculosis in DDTRP BIOINFORMATION  open access 
 
ISSN 0973-2063 (online) 0973-8894 (print)     
Bioinformation 7(2): 98-101 (2011)  100   © 2011 Biomedical Informatics
 
Future Developments:  
The database will be periodically updated with drug resistance 
related information and extended to include pathogens 
responsible for other emerging and re-emerging infectious 
diseases.  
  
Conclusion:  
The Database of Drug Targets for Resistant Pathogens (DDTRP) 
is a comprehensive database that provides a list of current and 
alternative drug targets for a group of pathogens of public 
health significance. This database would be an useful online 
resource for researchers involved in target identification and 
drug discovery for various infectious diseases.  
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Supplementary material: 
 
Table 1: Summary of data available in the DDTRP 
S. No   Pathogen   Number of drugs 
included in the 
database  
Number of current 
targets included in 
the database  
Number of    
target-metabolic 
pathways   
Number of 
potential 
alternate targets  
1   Mycobacterium 
tuberculosis  
12   12   11   86  
2   Mycobacterium 
leprae  
3   4   4   16  
3   Staphylococcus 
aureus  
4   7   5   47 
4   Streptococcus 
pneumoniae  
8   10   7   43  
5   Plasmodium 
falciparum  
6   5   3   16  
6   Plasmodium 
vivax  
6   5   3   11  
7   Neisseria 
gonorrhoeae  
7   9   7   46  
Total Number   46   52   40   265    
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 